French investigators assessed the self-reported use of cannabis on immune function in a cohort of nearly 1,000 patients co-infected with HIV and hepatitis C. Authors reported “no evidence [of] a negative effect of cannabis use on circulating CD4 T-cell counts/percentages.”
Separate clinical data published in 2013 in the journal Clinical Infectious Diseases reported that the long-term use of cannabis did not adversely impact liver function in patients co-infected with HIV and the hepatitis C virus.
Subjects diagnosed with HIV and/or hepatitis C frequently acknowledge using cannabis to treat disease symptoms as well as the side-effects associated with conventional drug therapies, such as nausea and appetite loss.
Full text of the study, “No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients,” appears in Drug and Alcohol Review.
You have used up your free articles for this month. To continue reading click here to login or subscribe.